---
title: "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287687352.md"
description: "MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News"
datetime: "2026-05-26T15:00:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287687352.md)
  - [en](https://longbridge.com/en/news/287687352.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287687352.md)
---

# MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News

MediciNova Announces Completion of Last Patient Last Visit in the MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast) | MNOV Stock News

### Related Stocks

- [4875.JP](https://longbridge.com/en/quote/4875.JP.md)
- [MNOV.US](https://longbridge.com/en/quote/MNOV.US.md)

## Related News & Research

- [MediciNova, Inc. (NASDAQ:MNOV) Given Consensus Rating of "Moderate Buy" by Analysts](https://longbridge.com/en/news/293839773.md)
- [MediciNova says SEANOBI-ALS expanded-access study of MN-166 reaches 200-patient enrollment target](https://longbridge.com/en/news/292763424.md)
- [ASX Growth Stocks With High Insider Confidence](https://longbridge.com/en/news/294612583.md)
- [MediciNova says US patent office allows ibudilast–anti-PD-1 combo claims for glioblastoma treatment](https://longbridge.com/en/news/291279545.md)
- [Seven Fleet Capital Management LP Acquires New Shares in Alkermes plc $ALKS](https://longbridge.com/en/news/294604011.md)